Growth Metrics

QuidelOrtho (QDEL) Cash from Operations Growth (1y) (2023 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Ops. Growth (1y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -7.20%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 132.40%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 6.69%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn -35.67%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -84.38%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 122.43%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 185.96%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 16.00%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 28.60%
10 QuidelOrtho 898.19 Mn 757.79 Mn - -150.30%

Historic Data

Download Data 🔒
DateValue
Mar 29, 2026 -150.30%
Dec 28, 2025 107.06%
Sep 28, 2025 -138.59%
Jun 29, 2025 52.20%
Mar 30, 2025 9,471.43%
Dec 29, 2024 -20.77%
Sep 29, 2024 184.10%
Jun 30, 2024 -219.93%
Mar 31, 2024 -100.37%
Dec 31, 2023 -79.94%
Apr 2, 2023 -62.29%